Target Overview: JBH Santé

JBH Santé specializes in organizing medical congresses in ophthalmology, rheumatology, and gynecology and publishes three medical journals focusing on these specialties. The company is renowned for hosting the Journées de Réflexions Ophtalmologiques (JRO), France’s leading annual ophthalmology congress, and actively organizes several regional congresses and symposiums that address specific ophthalmological themes.

Founded over 25 years ago by Dr. Jacques Halimi, a rheumatologist, JBH Santé was acquired in 2021 by Emmanuelle Gorsse, a seasoned events organizer, along with three active private investors. Under Gorsse's leadership, the company has successfully enhanced its digital transformation, initiated during the pandemic, and introduced four new congresses in their specialized fields. Additionally, Gorsse has improved JBH Santé's financial performance by increasing advertising revenues from the journals and streamlining congress organization costs.

Industry Overview in France

The healthcare sector in France is characterized by a robust framework that supports various medical services and educational events aimed at continuous professional development for healthcare professionals. France is home to a significant number of medical congresses annually, reflecting the country’s commitment to medical education and innovation.

The congress and symposium market in France has gained momentum, particularly exacerbated by the digital shift catalyzed by the COVID-19 pandemic. Hybrid events combining both in-person and virtual formats are becoming increasingly popular, allowing wider participation and accessibility to medical professionals across the country.

Furthermore, the increasing demand for specialized medical congresses is augmented by the need for ongoing education regarding advancements in healthcare practices. This growth creates significant opportunities for companies like JBH Santé to establish new events and expand their market reach.

Additionally, as health awareness among the public grows, collaboration between event organizers and medical practitioners becomes essential. This synergy not only boosts the profiles of medical events but also enhances the overall quality of healthcare services provided in France.

Rationale Behind the Deal

The acquisition of JBH Santé by France Conventions represents a strategic move to penetrate the healthcare sector, diversifying France Conventions' portfolio from contemporary art and real estate events to the medical field. JBH Santé's strong market presence and established platform for medical congresses provide an excellent foundation for growth.

Emmanuelle Gorsse’s confidence in France Conventions suggests a commitment to sustaining and enhancing the growth trajectory of JBH Santé, with expectations to leverage existing relationships and expand into new opportunities within the healthcare arena.

Investor Overview: France Conventions

France Conventions, led by siblings Julien and Valentine Lecêtre, is a prominent organizer of major events, specializing in contemporary art and real estate exhibitions. The company has built a strong reputation for hosting reference events such as Art Paris and Sibca. The decision to enter the healthcare market through the acquisition of JBH Santé is poised to capitalize on the resilient nature of the medical sector.

The Lecêtre siblings have articulated their goal of leveraging JBH Santé’s established position to create new congresses while also embarking on consultancy and scientific studies. This acquisition aligns with their vision of expansion and diversification, indicating their commitment to harnessing opportunities in various industries.

View of Dealert

The acquisition of JBH Santé by France Conventions signals a potentially favorable investment. The healthcare sector consistently demonstrates resilience, making it an attractive domain for growth and innovation. JBH Santé’s established presence and track record in organizing significant medical events provide a solid basis for France Conventions to expand its footprint in this field.

Moreover, the strategic alignment for hosting new congresses and building upon JBH Santé's strong client base is promising. The emphasis on digital transformation and increased advertising revenues will likely enhance JBH Santé's financial viability, further supporting the investor’s objectives.

Lastly, considering the increasing significance of continuing medical education, the potential for integrating hybrid event formats will likely attract broader audiences, fostering increased participation and engagement. Overall, this acquisition appears to be a well-timed move that capitalizes on current market dynamics while positioning both companies for sustained growth.

View Original Article